| Pharmaceutical Information |
| Drug Name |
Levobunolol |
| Drug ID |
BADD_D01267 |
| Description |
A nonselective beta-adrenoceptor antagonist used in the treatment of glaucoma. |
| Indications and Usage |
For lowering intraocular pressure (IOP) and may be used in patients with chronic open-angle glaucoma or ocular hypertension. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
S01ED03 |
| DrugBank ID |
DB01210
|
| KEGG ID |
D08115
|
| MeSH ID |
D002040
|
| PubChem ID |
39468
|
| TTD Drug ID |
D00IUG
|
| NDC Product Code |
Not Available |
| Synonyms |
Levobunolol | Apo-Levobunolol | Apo Levobunolol | ApoLevobunolol | Betagan | Levobunolol Hydrochloride | Novo-Levobunolol | Novo Levobunolol | NovoLevobunolol | W-7000A | W 7000A | W7000A | ratio-Levobunolol | ratio Levobunolol | Ultracortenol | Vistagan | AKBeta | PMS-Levobunolol | PMS Levobunolol | PMSLevobunolol |
|
| Chemical Information |
| Molecular Formula |
C17H25NO3 |
| CAS Registry Number |
47141-42-4 |
| SMILES |
CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
